The Excedrin recall in January was a big, and not just for its manufacturer. Since then, customers loyal to the brand have been searching high and low for the product — and anxiously awaiting its return.
Now, there’s light at the end of the tunnel. Excedrin Migraine is due back on store shelves by early October, says Milicent Brooks of Novartis, its producer. Other products involved in the recall will roll out after that.
That’s not a moment too soon for headache sufferers like Katie Brooke, 25, a restaurant manager in Orlando. Like legions of other headache sufferers, she was dismayed to find the store shelves empty of the headache remedy when she needed to replenish her supply in February.